Objectives: Studies investigating the association between gene polymorphisms involved in homocysteine/folate metabolism and Down syndrome (DS) have reported contradictory or inconclusive results. A meta-analysis of 25 studies on association between MTHFR and MTRR polymorphism and DS including 1, 934/2,081/ cases/controls for MTHFR C677T polymorphism, 1,404/1,632/ cases/control for MTHFR A1298C polymorphism and 859 /1,132/cases/ control for MTRR A66G polymorphism was carried out.
Introduction
Down syndrome (DS) is one of the commonest disorders with huge medical and social cost. The major cause of DS is the presence of three copies of genes located on chromosome 21.This change is attributed due to abnormal segregation of during meiosis with maternal non disjunction in around 90% of the cases primarily during meiosis I in the maturing oocyte, before conception [1] .
The relationships between non disjunction and abnormal folate metabolism have gained interest recent years. The abnormal folate and methyl metabolism lead to DNA hypomethylation and abnormal chromosomal segregation leading to DNA breaks and aberrant chromosome segregation [2, 3] .
Studies have shown that MTHFR (methylenetetrahydrofolate reductase) and MTRR (methionine synthase reductase) are the two gene identified as one of the risk factors of DS which are involved in folate metabolism [4] [5] [6] [7] [8] [9] [10] .
Case-control studies that have investigated the association between DS and MTHFR C677T and A1298C and MTRR A66G polymorphisms have provided inconclusive results. This may be because each study involved small numbers of cases and controls due to which enough information was not available to demonstrate association. In order to shed some light on these inconclusive results, as well as to decrease the uncertainty in the effect size of the risk, a meta-analysis is performed in this article relating the MTHFR C677T, MTHFR A1298C and MTRR A66G gene polymorphisms with DS.
Statistical analysis
The association between MTHFR C677T, A1298C and MTRR A66G gene polymorphisms and DS risk was assessed by using the co dominant (677CT vs. CC, 677TT vs. CC; 1298AC vs. AA, 1298CC vs. AA; AG vs. AA, GG vs. AA), the dominant (677CT+TT vs. CC; 1298AC+CC vs. AA; AG+GG vs. AA) and the recessive (677TT vs. CC+CT; 1298CC vs. AA+AC; GG vs. AA+AG) models.
The strength of association of the MTHFR and MTRR gene polymorphisms with DS was measured by the ORs together with the 95% CIs. The Chi-square test was first used to assess whether the distribution of genotypes among controls conformed to the Hardy-Weinberg equilibrium (HWE), with P<0.05 considered a departure from HWE. 
Results

Selection of studies
Meta analysis
The meta-analysis of the 18 populations demonstrated that MTHFR C677T was associated with increased DS risk under the homozygote (TT vs. CC: OR=2.991; 95% CI: 1.321-3.558; P=0.001) ( (Figures 1-3 
Discussions
Folate is an important vitamin that contributes to cell division and growth and is therefore of particular importance during infancy and pregnancy. Folate deficiency during conception and early pregnancy has been associated with slow growth, anemia, weight loss, digestive disorders, and neural tube defects. It has been suggested that certain polymorphism present on folate metabolizing genes can increase a risk of conceive baby with DS.
James et al in 1999 have reported a folate metabolizing gene, MTHFR as one of the risk factor for DS babies and have also suggested that a significant increase in plasma homocysteine levels exists in mothers of DS babies [9, 11] .
MTHFR gene contains 11 exons, located on chromosome 1p36.3 which encodes for an enzyme methylenetetrahydrofolate reductase (MTHFR), a key enzyme in folate and homocysteine metabolism. MTHFR is composed of an N-terminal catalytic and a C-terminal regulatory domain [12] . It catalyzes the biologically irreversible reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which provides the methyl group for the remethylation of homocysteine The area of the squares reflects the study-specific weight [14, 16, 21, [24] [25] [26] 30] .
to methionine [13] . Several single nucleotide polymorphisms are associated with MTHFR including C677T and A1298C which can affect folate and total homocysteine status. The C677T lies at the catalytic domain and the A1298C position is at the regulatory domain.
The MTHFR C677T, which involves a cytosine (C) to thymine (T) substitution at position 677 which changes amino acid from alanine to valine in the enzyme. The C677T increases thermolability of MTHFR and causes impaired folate binding and reduced activity of the MTHFR enzyme [14] . The MTHFR A1298C is due to adenine(A) to cytosine (C) transversion at nucleotide 1298, which produces a glutamate to alanine substitution. The A1298C polymorphism in the MTHFR gene has also been associated with decreased enzyme activity [4, 5] .
MTRR gene is located at 5p15.31 which maintains the methionine synthase enzyme at an active stage for the remethylation of homocysteine to methionine [6] . Methionine synthase reductase regenerates a functional methionine synthase via reductive methylation. Single nucleotide polymorphism in MTRR gene like A66G is found to affect the homocystein levels in humans [7, 8] . The A66G polymorphism in the MTRR gene causes the substitution of isoleucin with the methionine at codon 22 [9] . This polymorphism might be a genetic risk factor for DS since the methionine synthase reaction is important in maintaining normal folate metabolism and DNA methylation.
The meta-analysis examined the MTHFR and MTRR gene polymorphism and their relationship to risk of DS. The frequency of 677T and 1298C allele was found to be significantly higher among DS children than the other groups indicating that MTHFR C677T and MTHFR A1298C polymorphism in DS children would be expected to play an important role in bringing about DS. Some studies reported significantly increased prevalence of MTHFR C677T polymorphism as important risk factors for DS babies while in contrast some studies had also reported insignificant association [15] [16] [17] [18] . For MTHFR A1298C polymorphism, much more contradictory reports have been presented [16, 17, [19] [20] [21] [22] [23] [24] [25] . Differences in ethnicity may be one reason for controversy and high intake of food folate may neutralize the metabolic impact of MTHFR polymorphism [26] .
The T and C allele variant of MTHFR C677T and A1298C respectively may increase the thermolability of MTHFR gene thereby leading to production of abrupt homocysteine levels causing hypomethylation. Hypomethylation leads to abnormal chromosomal segregation which in turns leads to the risk of elevated trisomic fetuses. However this mechanism of abrupt homocysteine causing DNA methylation needs further elucidation and other risk factors must be studied properly on larger case -control study which is the main limitations of the study.
The pooled results indicate the homozygous and heterozygous variant of MTHFR C677T polymorphism exerted a risk on DS development (OR=2.991, 95% CI: 1.321-3.558 and OR=1.616, 95% CI: 1.216-1.845, respectively). However, when the analysis was performed by ethnicity, this was not observed in all subgroups except for Caucasian population (OR=1.709; 95% CI: 1,083-1.209). Similarly, when the study was stratified by ethnicity for dominant model, all three sub group showed increased risk of DS but these effect were reduced overall population of DS (OR=07528, 95% CI=0.8115-0.8503).
Again, the pooled results of MTHFR A1298C polymorphism of homozygous variant exerted a risk on DS development (OR=1.428, 95% CI: 1.016-1.849). However, when the analysis was performed by ethnicity, this was not observed in either of the subgroups.
In MTRR A66G polymorphism, reduced risk was observed in all variant but when this risk was stratified in dominant variant, the risk was observed in both Caucasian and Brazilian subgroups (AG+GG vs. AA; OR=1.555, 95% CI: 1.021-2.219 and OR=1.417, 95% CI; 0.999-2.006, respectively) yet this did not produce any overall effect on dominant model. Further well designed large scale case -control studies might be required to validate the association in different population having the risk of DS.
